SPA
OFIX icon

Sherbrooke Park Advisers’s Orthofix Medical OFIX Stock Holding History

Sherbrooke Park Advisers’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,511
Closed -$286K – 698
2025
Q1 		$286K Buy
17,511
+3,421
+24% +$60.1K 0.13% 315
2024
Q4 		$246K Sell
14,090
-5,041
-26% -$87.7K 0.08% 492
2024
Q3 		$299K Buy
19,131
+8,675
+83% +$139K 0.07% 570
2024
Q2 		$139K Buy
+10,456
New +$143K 0.02% 800

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
AYAL Capital Advisors Toronto, Ontario, Canada $370M AUM 52.93% 1-Year Est. Return

Sherbrooke Park Advisers's OFIX Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Orthofix Medical (OFIX) in Q2 2025, closing a stake of 17,511 shares — an estimated $286K sold.

Sherbrooke Park Advisers first reported a position in OFIX in Q2 2024 and held it in 4 quarters. The position peaked at $299K in Q3 2024. 158 funds tracked by Wall St. Rank hold OFIX as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Orthofix Medical position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 17,511 Orthofix Medical shares in Q2 2025, an estimated $286K.
  • Sherbrooke Park Advisers first reported a position in Orthofix Medical in Q2 2024 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Orthofix Medical position peaked at $299K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.